{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Bidentis Bipinnatae Herba", "EGFR", "Gastric cancer", "MAPK1"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38822119", "DateRevised": {"Year": "2024", "Month": "05", "Day": "31"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1007/s00210-024-03169-6"], "ArticleDate": [{"Year": "2024", "Month": "06", "Day": "01"}], "Journal": {"ISSN": "1432-1912", "JournalIssue": {"PubDate": {"Year": "2024", "Month": "Jun", "Day": "01"}}, "Title": "Naunyn-Schmiedeberg's archives of pharmacology", "ISOAbbreviation": "Naunyn Schmiedebergs Arch Pharmacol"}, "ArticleTitle": "Exploring the anti-gastric cancer mechanism of action of Bidentis Bipinnatae Herba based on network pharmacology, molecular docking, and cellular experimental validation.", "Abstract": {"AbstractText": ["The purpose of this study is to explore the potential molecular mechanism of Bidentis Bipinnatae Herba against gastric cancer by using network pharmacology methods, molecular docking, and cellular experimental validation. Medicinal plants related to gastric cancer were queried through TCMSP, SymMap, and Herb databases. The TCSMP database (drug-likeness\u2009\u2265\u20090.18) was used to retrieve the bioactive constituents. TCSMP, SwissTargetPrediction, and Herb databases were used to retrieve the target genes, and Cytoscape software was used to construct the \"active ingredient-target\" network. After protein interaction analysis using String 11.0 platform, the hub genes were screened using CytoHubba. The obtained hub genes were uploaded to the cBioPortal for pathway enrichment. The genes involved in gastric cancer-related RTK-RAS pathway were molecularly docked and experimentally validated. Bidentis Bipinnatae Herba was common to TCMSP, SymMap, and Herb databases. A total of nine active ingredients were obtained in Bidentis Bipinnatae Herba, acting on 192 targets. Seven hub genes were obtained from these target genes and enriched in the RTK-RAS pathway in gastric cancer. MAPK1 and EGFR had good molecular docking results with their corresponding chemicals. Cellular experiments showed that the treatment of luteolin, quercetin, and Okanin reduced the expression of EGFR in AGS cells; the treatment of luteolin and quercetin could reduce the expression of MAPK1. Bidentis Bipinnatae Herba contained active components, which may be anti-gastric cancer in a multi-target (MAPK1 and EGFR) manner."], "CopyrightInformation": "\u00a9 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Oncology, Yizheng Hospital of TCM, Yizheng, 211400, China."}], "LastName": "Guo", "ForeName": "Linglong", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Graduate School, Zhejiang Chinese Medical University, Zhejiang, 310053, China."}], "LastName": "Zhou", "ForeName": "Yuyi", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Traditional Chinese Medicine, Nanjing Luhe People's Hospital, No. 9, Jiankang Lane, Xiongzhou Street, Luhe District, Nanjing, 211500, China. maruidr@163.com."}], "LastName": "Ma", "ForeName": "Rui", "Initials": "R"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Naunyn Schmiedebergs Arch Pharmacol", "NlmUniqueID": "0326264", "ISSNLinking": "0028-1298"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Aventurado CA, Billones JB, Vasquez RD, Castillo AL (2020) In Ovo and in Silico evaluation of the anti-angiogenic potential of Syringin. Drug Des Devel Ther 14:5189\u20135204. https://doi.org/10.2147/dddt.s271952", "ArticleIdList": ["10.2147/dddt.s271952", "33268982", "7701684"]}, {"Citation": "Bartolome AP, Villase\u00f1or IM, Yang WC (2013) Bidens pilosa L. (Asteraceae): Botanical Properties, Traditional Uses, Phytochemistry, and Pharmacology. Evid Based Complement Alternat Med 2013:340215.\u00a0 https://doi.org/10.1155/2013/340215"}, {"Citation": "Cai J, Shi SY, Cheng F, Wei M, Zou K, Yu XQ, Chen JF (2023) Polyacetylene isomers isolated from Bidens pilosa L. suppress the metastasis of gastric Cancer cells by inhibiting Wnt/\u03b2-Catenin and Hippo/YAP signaling pathways. Molecules 28(4). https://doi.org/10.3390/molecules28041837"}, {"Citation": "Chang CL, Liu HY, Kuo TF, Hsu YJ, Shen MY, Pan CY, Yang WC (2013) Antidiabetic effect and mode of action of cytopiloyne. Evid Based Complement Alternat Med 2013:685642.\u00a0 https://doi.org/10.1155/2013/685642"}, {"Citation": "Chia NY, Tan P (2016) Molecular classification of gastric cancer. Ann Oncol 27(5):763\u2013769. https://doi.org/10.1093/annonc/mdw040", "ArticleIdList": ["10.1093/annonc/mdw040", "26861606"]}, {"Citation": "Colapietro A, Mancini A, D\u2019Alessandro AM, Festuccia C (2019) Crocetin and Crocin from Saffron in Cancer Chemotherapy and Chemoprevention. Anticancer Agents Med Chem 19(1):38\u201347. https://doi.org/10.2174/1871520619666181231112453", "ArticleIdList": ["10.2174/1871520619666181231112453", "30599111"]}, {"Citation": "Deng N, Goh LK, Wang H, Das K, Tao J, Tan IB, Zhang S, Lee M, Wu J, Lim KH, Lei Z, Goh G, Lim QY, Tan AL, Poh S, Riahi DY, Bell S, Shi S, Linnartz MM, Zhu R, Yeoh F, Toh KG, Yong HC, Cheong WP, Rha HC, Boussioutas SY, Grabsch A, Rozen H, S., Tan P (2012) A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets. Gut 61(5):673\u2013684. https://doi.org/10.1136/gutjnl-2011-301839", "ArticleIdList": ["10.1136/gutjnl-2011-301839", "22315472"]}, {"Citation": "Haghi A, Azimi H, Rahimi R (2017) A Comprehensive Review on Pharmacotherapeutics of three phytochemicals, Curcumin, Quercetin, and Allicin, in the treatment of gastric Cancer. J Gastrointest Cancer 48(4):314\u2013320. https://doi.org/10.1007/s12029-017-9997-7", "ArticleIdList": ["10.1007/s12029-017-9997-7", "28828709"]}, {"Citation": "Hou Y, Li G, Wang J, Pan Y, Jiao K, Du J, Chen R, Wang B, Li N (2017) Okanin, effective constituent of the flower tea Coreopsis tinctoria, attenuates LPS-induced microglial activation through inhibition of the TLR4/NF-\u03baB signaling pathways. Sci Rep 7:45705. https://doi.org/10.1038/srep45705", "ArticleIdList": ["10.1038/srep45705", "28367982", "5377376"]}, {"Citation": "L\u00f3pez MJ, Carbajal J, Alfaro AL, Saravia LG, Zanabria D, Araujo JM, Quispe L, Zevallos A, Buleje JL, Cho CE, Sarmiento M, Pinto JA, Fajardo W (2023) Characteristics of gastric cancer around the world. Crit Rev Oncol Hematol 181:103841. https://doi.org/10.1016/j.critrevonc.2022.103841", "ArticleIdList": ["10.1016/j.critrevonc.2022.103841", "36240980"]}, {"Citation": "Martins AFL, Pereira CH, Morais MO, de Sousa-Neto SS, Valadares MC, Freitas NMA, Leles CR, de Mendon\u00e7a EF (2023) Effects of a mucoadhesive phytomedicine (Curcuma longa L. and Bidens pilosa L.) on radiotherapy-induced oral mucositis and quality of life of patients undergoing head and neck cancer treatment: randomized clinical trial. Support Care Cancer 31(9):517. https://doi.org/10.1007/s00520-023-07971-5", "ArticleIdList": ["10.1007/s00520-023-07971-5", "37566179"]}, {"Citation": "Morgan E, Arnold M, Camargo MC, Gini A, Kunzmann AT, Matsuda T, Meheus F, Verhoeven RHA, Vignat J, Laversanne M, Ferlay J, Soerjomataram I (2022) The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: a population-based modelling study. EClinicalMedicine 47:101404. https://doi.org/10.1016/j.eclinm.2022.101404", "ArticleIdList": ["10.1016/j.eclinm.2022.101404", "35497064", "9046108"]}, {"Citation": "Onoyama T, Ishikawa S, Isomoto H (2022) Gastric cancer and genomics: review of literature. J Gastroenterol 57(8):505\u2013516. https://doi.org/10.1007/s00535-022-01879-3", "ArticleIdList": ["10.1007/s00535-022-01879-3", "35751736", "9308599"]}, {"Citation": "Pathak K, Pathak MP, Saikia R, Gogoi U, Sahariah JJ, Zothantluanga JH, Samanta A, Das A (2022) Cancer Chemotherapy via Natural Bioactive compounds. Curr Drug Discov Technol 19(4):e310322202888. https://doi.org/10.2174/1570163819666220331095744", "ArticleIdList": ["10.2174/1570163819666220331095744", "35362385"]}, {"Citation": "Ping MH (2020) Hyperin controls the development and therapy of gastric Cancer via regulating Wnt/\u03b2-Catenin signaling. Cancer Manag Res 12:11773\u201311782. https://doi.org/10.2147/cmar.s270544", "ArticleIdList": ["10.2147/cmar.s270544", "33235505", "7680131"]}, {"Citation": "Pu Y, Zhang T, Wang J, Mao Z, Duan B, Long Y, Xue F, Liu D, Liu S, Gao Z (2018) Luteolin exerts an anticancer effect on gastric cancer cells through multiple signaling pathways and regulating miRNAs. J Cancer 9(20):3669\u20133675. https://doi.org/10.7150/jca.27183", "ArticleIdList": ["10.7150/jca.27183", "30405835", "6215998"]}, {"Citation": "Rao X, Zhang C, Luo H, Zhang J, Zhuang Z, Liang Z, Wu X (2022) Targeting gastric Cancer stem cells to Enhance Treatment Response. Cells 11(18). https://doi.org/10.3390/cells11182828"}, {"Citation": "Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F (2020) Gastric cancer. Lancet 396(10251):635\u2013648. https://doi.org/10.1016/s0140-6736(20)31288-5", "ArticleIdList": ["10.1016/s0140-6736(20)31288-5", "32861308"]}, {"Citation": "Tang C, Zhao CC, Yi H, Geng ZJ, Wu XY, Zhang Y, Liu Y, Fan G (2020) Traditional Tibetan Medicine in Cancer Therapy by Targeting apoptosis pathways. Front Pharmacol 11:976. https://doi.org/10.3389/fphar.2020.00976", "ArticleIdList": ["10.3389/fphar.2020.00976", "32774302", "7381342"]}, {"Citation": "Tao H, Wu X, Cao J, Peng Y, Wang A, Pei J, Xiao J, Wang S, Wang Y (2019) Rhodiola species: a comprehensive review of traditional use, phytochemistry, pharmacology, toxicity, and clinical study. Med Res Rev 39(5):1779\u20131850. https://doi.org/10.1002/med.21564", "ArticleIdList": ["10.1002/med.21564", "30652331"]}, {"Citation": "Thrift AP, El-Serag HB (2020) Burden of gastric Cancer. Clin Gastroenterol Hepatol 18(3):534\u2013542. https://doi.org/10.1016/j.cgh.2019.07.045", "ArticleIdList": ["10.1016/j.cgh.2019.07.045", "31362118"]}, {"Citation": "Thrift AP, Wenker TN, El-Serag HB (2023) Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention. Nat Rev Clin Oncol 20(5):338\u2013349. https://doi.org/10.1038/s41571-023-00747-0", "ArticleIdList": ["10.1038/s41571-023-00747-0", "36959359"]}, {"Citation": "Xia X, Ma Y, Xing X, Huang C, Li L, Gui G, Liu Q, Xue S (2013) Antioxidant and hepatoprotective effect of different extracts of guizhencao (herba bidentis bipinnatae) against liver injury in hyperlipidemia rats. J Tradit Chin Med 33(4):518\u2013523. https://doi.org/10.1016/s0254-6272(13)60158-2", "ArticleIdList": ["10.1016/s0254-6272(13)60158-2", "24187875"]}, {"Citation": "Xia C, Dong X, Li H, Cao M, Sun D, He S, Yang F, Yan X, Zhang S, Li N, Chen W (2022) Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl) 135(5):584\u2013590. https://doi.org/10.1097/cm9.0000000000002108", "ArticleIdList": ["10.1097/cm9.0000000000002108", "35143424"]}, {"Citation": "Yadav SS, Singh MK, Singh PK, Kumar V (2017) Traditional knowledge to clinical trials: a review on therapeutic actions of Emblica officinalis. Biomed Pharmacother 93:1292\u20131302. https://doi.org/10.1016/j.biopha.2017.07.065", "ArticleIdList": ["10.1016/j.biopha.2017.07.065", "28747010"]}, {"Citation": "Yan HHN, Siu HC, Law S, Ho SL, Yue SSK, Tsui WY, Chan D, Chan AS, Ma S, Lam KO, Bartfeld S, Man AHY, Lee BCH, Chan ASY, Wong JWH, Cheng PSW, Chan AKW, Zhang J, Shi J, Fan X, Kwong DLW, Mak TW, Yuen ST, Clevers H, Leung SY (2018) A Comprehensive Human gastric Cancer Organoid Biobank captures Tumor Subtype Heterogeneity and enables therapeutic screening. Cell Stem Cell 23(6):882\u2013897e811. https://doi.org/10.1016/j.stem.2018.09.016", "ArticleIdList": ["10.1016/j.stem.2018.09.016", "30344100"]}, {"Citation": "Yang WC (2014) Botanical, Pharmacological, Phytochemical, and Toxicological Aspects of the Antidiabetic Plant Bidens pilosa L. Evid Based Complement Alternat Med 2014:698617.\u00a0 https://doi.org/10.1155/2014/698617"}, {"Citation": "Yang WJ, Zhao HP, Yu Y, Wang JH, Guo L, Liu JY, Pu J, Lv J (2023) Updates on global epidemiology, risk and prognostic factors of gastric cancer. World J Gastroenterol 29(16):2452\u20132468. https://doi.org/10.3748/wjg.v29.i16.2452", "ArticleIdList": ["10.3748/wjg.v29.i16.2452", "37179585", "10167900"]}, {"Citation": "Zang MD, Hu L, Fan ZY, Wang HX, Zhu ZL, Cao S, Wu XY, Li JF, Su LP, Li C, Zhu ZG, Yan M, Liu BY (2017) Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the notch signaling pathway. J Transl Med 15(1):52. https://doi.org/10.1186/s12967-017-1151-6", "ArticleIdList": ["10.1186/s12967-017-1151-6", "28241766", "5327575"]}]}], "History": [{"Year": "2024", "Month": "4", "Day": "1"}, {"Year": "2024", "Month": "5", "Day": "16"}, {"Year": "2024", "Month": "6", "Day": "1", "Hour": "10", "Minute": "51"}, {"Year": "2024", "Month": "6", "Day": "1", "Hour": "10", "Minute": "51"}, {"Year": "2024", "Month": "5", "Day": "31", "Hour": "23", "Minute": "28"}], "PublicationStatus": "aheadofprint", "ArticleIdList": ["38822119", "10.1007/s00210-024-03169-6", "10.1007/s00210-024-03169-6"]}}]}